Evidence map›Paper›PMID 26427566›Full record

ArticleEuropean urology2016

PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2.

Jeffrey C Weinreb, Jelle O Barentsz, Peter L Choyke, Francois Cornud, Masoom A Haider, Katarzyna J Macura, Daniel Margolis, Mitchell D Schnall, Faina Shtern, Clare M Tempany and 2 more

9 registry-linked trialsAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European urology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 9 registered trials, which are not on this map. Cited by 1,374 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1,374citing papers in PubMed, 6 pooled it
176.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03615131 completednot on this map

Accuracy of Multi-parametric Prostate MRI and MRI-targeted, Ultrasound-navigated Prostate Fusion Biopsy in the Detection of Prostate Cancer:

TypeobservationalSponsorKantonsspital Winterthur KSWRan2015 to 2017Enrolled157ConditionsProstate CancerArmsMRI-TRUS fusion prostate biopsy
NCT03624660 phase2active not recruitingnot on this mapstarted 2018, after this paper: background citation

A Phase II Study of Dose-Escalated Proton-Based Radiation Therapy Delivered With a Simultaneous Integrated Boost (SIB) to Intraprostatic Tumors (IPT) Visible on Pretreatment Magnetic Resonance Image

TypeinterventionalSponsorUniversity of FloridaRan2018 to 2029Enrolled100ConditionsAdenocarcinoma of the ProstateArmsHR-A, HR-B
NCT03891732 active not recruitingnot on this mapstarted 2019, after this paper: background citation

The Use of MRI Prostate in Improving Detection of Significant Prostate Cancer in a Screening Population of Chinese Men With Elevated PSA

TypeobservationalSponsorChinese University of Hong KongRan2019 to 2024Enrolled690ConditionsProstate Cancer, PSA, MRIArmsMRI prostate
NCT03936127 naunknown statusnot on this mapstarted 2022, after this paper: background citation

Comparison of a Novel Transperineal Targeted Fusion Biopsy System to Conventional Transrectal Targeted Fusion Biopsy for Diagnosis of Clinically Significant Prostate Cancers and to Eliminate Post-procedure Related Infections: A Randomized Control Trial

TypeinterventionalSponsorDr. Nicola SchiedaRan2022 to 2024Enrolled360ConditionsProstate CancerArmsUltrasound (US) Targeted Fusion Biopsy
NCT05004285 phase3active not recruitingnot on this mapstarted 2021, after this paper: background citation

A Multi Center, Non-randomized, Open, Phase 3 Study to Evaluate the Clinical Usefulness of [F-18]Florastamin PET/CT Imaging Diagnosis Compared to MRI Diagnosis in Prostate Cancer Risk Groups

TypeinterventionalSponsorFutureChemRan2021 to 2025Enrolled398ConditionsHigh Risk Prostate CarcinomaArms[F-18]Florastamin
NCT05024162 narecruitingnot on this mapstarted 2022, after this paper: background citation

Can Magnetic Resonance Imaging of the Prostate Combined With a Radiomics Evaluation Determine the Invasive Capacity of a Tumour (Can MRI-PREDICT)

TypeinterventionalSponsorNova Scotia Health AuthorityRan2022 to 2025Enrolled60ConditionsProstate CancerArmsMRT Accuracy, MRT Stability
NCT05498623 completednot on this mapstarted 2022, after this paper: background citation

MR Fingerprinting of the Prostate - Towards Improved Patient Care with High Speed Quantitative Imaging

TypeobservationalSponsorNorwegian University of Science and TechnologyRan2022 to 2023Enrolled203ConditionsProstate Cancer, Magnetic Resonance Imaging
NCT06116344 completednot on this mapstarted 2018, after this paper: background citation

Improving Prostate Lesion Classification and Diagnostic Accuracy Using Machine Learning: A Comprehensive Evaluation and Development of a PI-RADS 3 Classifier

TypeobservationalSponsorParacelsus Medical UniversityRan2018 to 2023Enrolled173ConditionsProstate Cancer
NCT07339943 narecruitingnot on this mapstarted 2025, after this paper: background citation

Micro-ultrasound-Guided Focal Laser Ablation (MicroUSgFLA) Treatment for Management of Intermediate-Risk Prostate Cancer: Evaluation of Safety and Effectiveness

TypeinterventionalSponsorUniversity Health Network, TorontoRan2025 to 2027Enrolled7ConditionsProstate Cancer (Adenocarcinoma), Low and Intermediate Risk Prostate CancerArms6 month, prospective, interventional single-arm safety and effectiveness study, The TRANBERG, CLS Thermal therapy
3 · Its place in the literature

Who cites it

1,374 citing papers in PubMed, 6 syntheses or guidelines pooled it, 2,887 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. [European journal of nuclear medicine and molecular imaging · 2026
    Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

1,314 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 12 institutions in 5 countries.

Jeffrey C WeinrebYale School of Medicine, New Haven, CT, USA. Electronic address: jeffrey.weinreb@yale.edu.
Jelle O BarentszRadboudumc, Nijmegen, The Netherlands.
Peter L ChoykeNational Institutes of Health, Bethesda, MD, USA.
Francois CornudRené Descartes University, Paris, France.
Masoom A HaiderUniversity of Toronto, Sunnybrook Health Sciences Centre, Toronto, Canada.
Katarzyna J MacuraJohns Hopkins University, Baltimore, MD, USA.
Daniel MargolisUniversity of California, Los Angeles, CA, USA.
Mitchell D SchnallUniversity of Pennsylvania, Philadelphia, USA.
Faina ShternAdMeTech Foundation, Boston, MA, USA.
Clare M TempanyHarvard University, Boston, MA, USA.
Harriet C ThoenyUniversity Hospital of Bern, Bern, Switzerland.
Sadna VermaUniversity of Cincinnati, Cincinnati, OH, USA.
AdMeTech Foundation · USHarvard University · USHealth Sciences Centre · CAJohns Hopkins University · USNational Institutes of Health · USRadboud University Medical Center · NLUniversité Paris Cité · FRUniversity Hospital of Bern · CHUniversity of California, Los Angeles · USUniversity of Cincinnati · USUniversity of Pennsylvania · USYale University · US

Funding

Prostate Cancer ImagingZIABC010655 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI CHOYKE, PETER L · 2009 to 2025
$49.2M
Intramural NIH HHS ZIA BC010655
6 · The paper itself

Abstract

The Prostate Imaging - Reporting and Data System Version 2 (PI-RADS™ v2) is the product of an international collaboration of the American College of Radiology (ACR), European Society of Uroradiology (ESUR), and AdMetech Foundation. It is designed to promote global standardization and diminish variation in the acquisition, interpretation, and reporting of prostate multiparametric magnetic resonance imaging (mpMRI) examination, and it is based on the best available evidence and expert consensus opinion. It establishes minimum acceptable technical parameters for prostate mpMRI, simplifies and standardizes terminology and content of reports, and provides assessment categories that summarize levels of suspicion or risk of clinically significant prostate cancer that can be used to assist selection of patients for biopsies and management. It is intended to be used in routine clinical practice and also to facilitate data collection and outcome monitoring for research.

Indexed as

Endoscopic Ultrasound-Guided Fine Needle AspirationHumansImage Interpretation, Computer-AssistedMagnetic Resonance ImagingMaleNeoplasm StagingProstateProstatic HyperplasiaProstatic NeoplasmsRadiology Information SystemsRisk AssessmentTerminology as TopicMagnetic resonance imagingProstateProstate cancerProstate mpMRIProstate MRI

Identifiers

PMID26427566
PMCPMC6467207
OpenAlexW1827911007

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

and 3 more above

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.